ELISA Analyzer Market-In-Depth Analysis of Business Overview, Current Trends, Prediction Overview, Key Company Profiles | By Service and Service-Provider | Global Industry Forecast – 2026
Enzyme-Linked Immunosorbent Assay (ELISA) is a commonly used analytical biochemistry assay. It uses antibodies and enzyme-mediated color change to detect the presence of either antigen (proteins, peptides, and hormones) or antibody in a sample. Enzyme-linked immunosorbent assay is majorly used as a diagnostic tool in medicine and analytical tool in biomedical research. ELISA analyzer is an instrument used for detecting the concentration and presence of analyte in the test sample. ELISA analyzer can also be used as a part of workflow were reagents and consumables that are fed to carry out ELISA and results are displayed on the screen attached to it, which is known as automated ELISA analyzer. Increasing array of products to ease the workflow is the major factor driving the ELISA analyzer market growth over the forecast period.
For more Information, Request PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-sample/1850
Growing prevalence of infectious diseases and drug development are expected to drive growth of the global ELISA analyzer market during the forecast period. However, stringent regulatory policies for product approval are expected to hinder the new product launches, which in turn is restraining growth of the market.
Global ELISA Analyzer Market Dynamics
Continuous launch of new products combined with increased sophistication and value added testing environment to improve sensitivity and compactness of product are expected drive growth of the global ELISA analyzer market during the forecast period. For instance, in 2017, Siemens Healthineers, received CE approval for Atellica Solution, an automated immunoassay and chemistry analyzers in Europe, the U.S., South America, and Asia.
The product consists of comprehensive menu of 170 assays, which includes cardiac, thyroid, and reproductive tests. Moreover, the company has pipeline of around 50 more assays, which are expected to be added to the present menu. In 2014, Sysmex Corporation introduced HISCL-800, a compact and automated immunoassay system used for the immunochemistry testing. The product is claimed to be more compact as compared to other products of same series.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1850
ELISA technique holds promising results in diagnosis of health related problems. Growing prevalence of infectious disease and cancer are expected to support growth of the global ELISA analyzer market over the forecast period. For instance, according to the World Health Organization (WHO), in 2016, an estimated cases of malaria in 91 countries across the globe were around 216 million, which increased by 5 million as compared to 2015. Moreover, funding and initiatives to eradicate the disease burden are expected to increase the adoption of diagnostic assay and advanced analyzer, which in turn, is expected to drive the global ELISA analyzer market growth in the near future.
Furthermore, increasing number of drug discovery programs by pharmaceutical and biopharmaceutical companies are driving demands for improved and advanced instrument to ease with good quality results in less time as a part of the workflow. According to International Federation of Pharmaceutical Manufacturers & Associations, in 2015, new 56 medicines were launched, while currently over 7,000 compounds are at different stages of development worldwide. Such drug discovery programs prominently use ELISA in the clinical trial, in turn increasing adoption of ELISA analyzer.
ELISA Analyzer Market – Regional Analysis
Regional segmentation of the market by Coherent Market Insights includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among regions, North America ELISA analyzer market holds dominant position in global market, owing to increasing burden of infectious disease, adoption of immunoassays in diagnosis, and presence of local market players. For instance, according to National Ambulatory Medical Care Survey, 2015, in the U.S. around 16.8 million visits were reported to physician offices for infectious and parasitic diseases.
However, Asia Pacific ELISA analyzer market is expected to witness rapid growth, owing to increasing demand from emerging economies such as India, where large patient population demands for rapid and high-throughput technology for test and detection of disease.
Browse Research Report At https://www.coherentmarketinsights.com/ongoing-insight/elisa-analyzer-market-1850
ELISA Analyzer Market – Competitive Analysis
Key players operating in the global ELISA analyzer market include Siemens Healthineers, Awareness Technology, Inc., Dynes Technologies, Inc., EUROIMMUN AG, Robimes, Gold Standard Diagnostics, Corp., BioTek Instruments, Inc., and Berthold Technologies GmbH & Co. KG.
In 2016, Gold Standard Diagnostics, Corp. and R-BioPharma AG collaborated on multiple technology and marketing initiatives to leverage respective strength of both companies to expand product offering and geographic sales coverage. In 2013, Gold Standard Diagnostics, Corp. established distribution partnership for the ThunderBolt automated immunoassay analyzer in 18 countries since its launch in 2012.
- In August 2019, PerkinElmer, Inc., introduced EUROIMMUN Aspergillus Antigen ELISA for detection of aspergillus infections.
- In 2017, Siemens Healthineers, received CE mark for Atellica Solution, which is an automated immunoassay and chemistry analyzer and are available in the U.S., Europe, South America, and Asian markets.
- In 2014, Sysmex Corporation launched HISCL-800, a compact and automated immunoassay system used for the immunochemistry testing.
- In 2012, Dynex Technologies Inc., received china state food and drug administration (SFDA) approval for its DS2 automated enzyme-linked immunosorbent assay (ELISA) analyzer in China. This DS2 assay is considered to be an automated ELISA processing system for clinical diagnostic assays.
- In 2012, Gold Standard Diagnostics, Corp. (GSD) launched fully automated ELISA platform thunderbolt
ELISA Analyzer Market Taxonomy
Based on mode of operation:
- 1 Plate
- 2 Plate
- 4 Plate
Based on application:
- Vaccines Development
- Drug Monitoring and Pharmaceutical Industry
Based on modality:
Based on end-user:
- Clinical Research Organizations
- Pharmaceutical and Biotechnology Companies
- Educational and Research Institutes
- Diagnostic Laboratories
Based on region:
- North America
- Latin America
- Asia Pacific
- Middle East
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire